secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vir Biotechnology, Inc. (VIR)
CIK:        0001706431
Form:       8-K
Filed at:   2024-04-18T23:59:59+00:00
Accession:  0001193125-24-100072
Event type: leadership
Sentiment:  positive
Materiality: 0.55
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CFO Sung Lee resigns effective May 3; board nominates two new independent directors
--------------------------------------------------------------------------------

- CFO Sung Lee resigns effective May 3, 2024, to pursue other opportunity; no disagreement with company.
- Board nominates Norbert Bischofberger and Ramy Farid as independent director candidates for May 29 annual meeting.
- Founders Phillip Sharp and Robert Perez will not stand for reelection at the annual meeting.
- Bischofberger brings 40 years biotech experience (former Gilead R&D head); Farid is CEO of Schrödinger.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1706431/000119312524100072/0001193125-24-100072-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1706431/000119312524100072/d824543d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-100072

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer